Stay updated on Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Added Hepatocellular carcinoma as a disease term and a link to the Genetic and Rare Diseases Information Center; updated the page revision from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-18T20:20:20.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Added revision: v3.4.3 and removed revision: v3.4.2. This is a metadata version update.
    Difference
    0.1%
    Check dated 2026-03-11T16:36:17.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The prior lapse-in-government-funding operating-status notice was removed.
    Difference
    0.4%
    Check dated 2026-02-11T00:27:42.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    A site-wide funding/operating status notice has been added, and the site version has been updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-03T22:44:14.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The page now shows a glossary option and includes meta-data updates: the 'Last Update Submitted that Met QC Criteria' label and a 'No FEAR Act Data' note were added, and the site revision updated from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T18:00:54.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. No changes to study content or critical functionality were observed.
    Difference
    0.1%
    Check dated 2026-01-20T14:18:52.000Z thumbnail image

Stay in the know with updates to Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial page.